title: The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy.
abstract: DNA-based vaccine strategy is increasingly realized as a viable cancer treatment approach. Strategies to enhance immunogenicity utilizing tumor associated antigens have been investigated in several pre-clinical and clinical studies. The promising outcomes of these studies have suggested that DNA-based vaccines induce potent T-cell effector responses and at the same time cause only minimal side-effects to cancer patients. However, the immune evasive tumor microenvironment is still an important hindrance to a long-term vaccine success. Several options are currently under various stages of study to overcome immune inhibitory effect in tumor microenvironment. Some of these approaches include, but are not limited to, identification of neoantigens, mutanome studies, designing fusion plasmids, vaccine adjuvant modifications, and co-treatment with immune-checkpoint inhibitors. In this review, we follow a Porter's analysis analogy, otherwise commonly used in business models, to analyze various immune-forces that determine the potential success and sustainable positive outcomes following DNA vaccination using non-viral tumor associated antigens in treatment against cancer.
authors.affiliation: Department of Medicine, St. Thomas Health Mid-Town Hospital, Nashville, TN 37236, USA. suneetha.amara@sth.org.
authors.forename: Suneetha
authors.initials: S
authors.lastname: Amara
authors.affiliation: Department of Biological Sciences, Tennessee State University, 3500 John A Merritt Blvd, Nashville, TN 37209, USA. vtirivee@tnstate.edu.
authors.forename: Venkataswarup
authors.initials: V
authors.lastname: Tiriveedhi
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D006801:Humans; D057131:Immune Evasion; D007114:Immunization / Q000379:methods*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*
chemical_list: D019496:Cancer Vaccines; D019444:Vaccines, DNA
keywords: DNA vaccine; T-cells; cytokines; immune checkpoint inhibitors; tumor associated antigens